Drug Trial Radar · NCT04944979
Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)
Last checked: Nov 20, 2026Latest source record: May 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Mar 31, 2021
Primary completion
Dec 2026
Study completion May 2027
Sponsor
- Lead sponsor
- Kedrion S.p.A.Industry
- Sponsor type
- Industry
- First posted
- Jun 30, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess efficacy, safety and pharmacokinetics of Kedrion Immunoglobulin 10% (KIg10) in pediatric patients with Primary Immunodeficiency Disease (PID).
Conditions
- Primary Immunodeficiency Disease
Interventions
Kedrion IVIG 10%Biological
Kedrion intravenous immunoglobulin (IVIg) 10%
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence Rate of Acute Serious Bacterial InfectionsTime frame: From Baseline (Day 1) up to week 51/52
Locations
21 sites in 6 countries. Site status is shown where the registry gives one.
Benioff Children's Hospital - Mission Bay
San Francisco, California
IMMUNOe Health and Research Centers
Centennial, Colorado
Johns Hopkins All Children's Hospital
St. Petersburg, Florida
Velocity Clinical Research - MedPharmics - Lafayette
Lafayette, Louisiana
Louisiana State University Shreveport
Shreveport, Louisiana
Duke Children's Hospital & Health Center
Durham, North Carolina
Asthma and Allergy Center - Toledo
Toledo, Ohio
Vital Prospects Clinical Research Institute PC
Tulsa, Oklahoma
Dél-Pesti Centrumkórház - Országos Hematológiai És Infektológiai Intézet
Budapest, Hungary
SST Spedali Civili di Brescia
Brescia, Italy
Azienda Ospedaliero-Universitaria - Ospedale Pediatrico Meyer
Florence, Italy
I.R.C.C.S. Istituto Giannina Gaslini
Genova, Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinic
Milan, Italy
Azienda Ospedaliera Universitaria "Federico II"
Naples, Italy
Fondazione Policlinico Tor Vergata
Roma, Italy
IRCCS Ospedale Pediatrico Bambino Gesù
Roma, Italy
Centro Hospitalar Lisboa Central - Hospital Dona Estefânia
Lisbon, Portugal
Centro Hospitalar Universitário do Porto - Hospital Santo António
Porto, Portugal
Children's City Clinical Hospital No. 9 named after G.N. Speransky, Moscow City Health Department
Moscow, Russia
Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology
Moscow, Russia
Národný ústav detských chorôb (National Institute of Pediatric Diseases)
Bratislava, Slovakia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.